Memphis Pharmaceuticals & Chemical Industries (EGX: MPCI)

Egypt flag Egypt · Delayed Price · Currency is EGP
60.06
-0.49 (-0.81%)
At close: Jan 26, 2025
-24.30%
Market Cap 1.34B
Revenue (ttm) 1.09B
Net Income (ttm) 307.55M
Shares Out 22.75M
EPS (ttm) 54.68
PE Ratio 1.08
Forward PE n/a
Dividend 4.00 (6.88%)
Ex-Dividend Date Nov 13, 2024
Volume 120,390
Average Volume 364,917
Open 60.55
Previous Close 60.55
Day's Range 60.02 - 62.00
52-Week Range 31.00 - 139.99
Beta 0.13
RSI 59.16
Earnings Date Feb 10, 2025

About EGX: MPCI

Memphis Pharmaceuticals & Chemical Industries, a drug holding company, produces and sells pharmaceutical products for human and veterinary use in Egypt and internationally. The company offers human health products in various therapeutic areas, including anti-infective, CNS, dermatological, cardio vascular system, corticosteroid, vitamins and minerals, musculo-skeletal system, analgesic and antipyretic, respiratory system, genitourinary system, alimentary tract and metabolism, antihistaminic, antiparasites, and hormones. It also provides animal ... [Read more]

Industry Pharmaceutical Preparations
Founded 1940
Employees 144
Stock Exchange Egyptian Stock Exchange
Ticker Symbol MPCI
Full Company Profile

Financial Performance

In 2024, MPCI's revenue was 871.91 million, an increase of 31.34% compared to the previous year's 663.83 million. Earnings were 191.46 million, an increase of 111.70%.

Financial Statements

News

There is no news available yet.